Pharmacokinetics of levetiracetam in neonates

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

TCTR

Registry ID

TCTR20161017001

Enrollment

Registered

2016-10-17

Start date

2016-02-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neonatal seizure Levetiracetam Neonate Neonatal seizure Pharmacokinetics

Interventions

Levetiracetam is a antiepileptic drug

Experimental Drug

Levetiracetam

Eligibility

Sex/Gender

All

Age

0 Years to 1 Months

Inclusion criteria

Inclusion criteria: All neonates with seizure who require antiepileptic drug

Exclusion criteria

Exclusion criteria: Impaired renal function: -Previous serum creatinine >/= 2 mg/dL or -Anuria in previous 24 hrs or No umbilical artery catheter or arterial line

Design outcomes

Primary

Measure	Time frame
Pharmacokinetics of levetiracetam in neonates 3 years Kinetica 2.0 (Thermo Fisher Scientific Inc., Waltham, MA, USA) PK MODEL	—

Secondary

Measure	Time frame
No No No	—

Countries

Thailand

Contacts

Public ContactNattha Worachat

Ramathibodi hospital, Mahidol university

nattha29@hotmail.com0815882574

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026